V023-1135 Screening compound: N-(butan-2-yl)-3-{3-[4-(butan-2-yloxy)phenyl]-5-oxo-2,5-dihydro-1,2,4-triazin-6-yl}propanamide

V023-1135 Screening compound: N-(butan-2-yl)-3-{3-[4-(butan-2-yloxy)phenyl]-5-oxo-2,5-dihydro-1,2,4-triazin-6-yl}propanamide
V023-1135 Screening compound: N-(butan-2-yl)-3-{3-[4-(butan-2-yloxy)phenyl]-5-oxo-2,5-dihydro-1,2,4-triazin-6-yl}propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V023-1135
N-(butan-2-yl)-3-{3-[4-(butan-2-yloxy)phenyl]-5-oxo-2,5-dihydro-1,2,4-triazin-6-yl}propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V023-1135

Molecular Formula

C20H28N4O3 (C20 H28 N4 O3)

Compound Name

N-(butan-2-yl)-3-{3-[4-(butan-2-yloxy)phenyl]-5-oxo-2,5-dihydro-1,2,4-triazin-6-yl}propanamide

IUPAC name

N-(butan-2-yl)-3-{3-[4-(butan-2-yloxy)phenyl]-5-oxo-25-dihydro-124-triazin-6-yl}propanamide

SMILES

CCC(C)NC(CCC1=NNC(c(cc2)ccc2OC(C)CC)=NC1=O)=O

InChI

InChI=1S/C20H28N4O3/c1-5-13(3)21-18(25)12-11-17-20(26)22-19(24-23-17)15-7-9-16(10-8-15)27-14(4)6-2/h7-10,13-14H,5-6,11-12H2,1-4H3,(H,21,25)(H,22,24,26)

InChI Key

GWSZWRHGZCEWLI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14263602

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

372.47

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.825

Distribution Coefficient, logD

1.883

Water Solubility, LogSw

-3.29

Polar Surface Area

77.178

Acid Dissociation Constant (pKa)

9.75

Base Dissociation Constant (pKb)

2.06

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

50.00

V023-1135 in Drug Discovery

Included in Screening Libraries

Protein Arginine Methyltransferases Library (27925 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V023-1135 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V023-1135?
Check Price and Availability of V023-1135, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V023-1135 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V023-1135
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V023-1135
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V023-1135 available by request